Market Tracker

05/02 6:45pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

17.61
Delayed Data
As of May 02
 +1.40 / +8.67%
Today’s Change
15.68
Today|||52-Week Range
56.16
-51.59%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close16.21
Today’s open16.74
Day’s range16.09 - 17.73
Volume836,382
Average volume (3 months)598,194
Market cap$467.8M
Dividend yield--
Data as of 4:00pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-136.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
CTMXCytomX Therapeutics ...+0.14+1.08%
SGYPSynergy Pharmaceutic...+0.17+5.41%
FLMLFlamel Technologies ...+0.86+7.50%
SCMPSucampo Pharmaceutic...-0.22-2.04%
Data as of 4:00pm ET, 05/02/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts